Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
'Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summer says
January 21, 2025
Tags
Davos WEF
LILLY DRN
Policy
From
CNBC.com News
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
January 18, 2025
Tags
AI / Artificial Intelligence
Internet
Amazon/com Inc
From
CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
January 17, 2025
Tags
Health care industry
Theravance Biopharma Inc
Pfizer Inc
From
CNBC.com News
Eli Lilly CEO expects new weight loss pill to be approved next year
January 13, 2025
Tags
LILLY DRN
Health & Science
Business
From
CNBC.com News
High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups
January 10, 2025
Tags
Business News
Health care industry
Pharmaceuticals
From
CNBC.com News
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
January 08, 2025
Tags
Business News
Novo Nordisk A/S
Biotech and Pharmaceuticals
From
CNBC.com News
Cramer's Lightning Round: 'I'd be careful' with Novo Nordisk
January 07, 2025
Tags
S&P 500
Investing
Business
From
CNBC.com News
Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown
December 24, 2024
Tags
Oscar Health Inc
Goodrx Holdings Inc
Novo Nordisk A/S
From
CNBC.com News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
December 24, 2024
Tags
Business News
Novo Nordisk A/S
Pharmaceuticals
From
CNBC.com News
CNBC Daily Open: With cooler-than-expected PCE, would the Fed’s dot plot have looked different?
December 22, 2024
Tags
Starbucks Corp
World Markets
Boeing Co
From
CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
December 20, 2024
Tags
Pharmaceuticals
Biotech and Pharmaceuticals
Novo Nordisk A/S
From
CNBC.com News
Novo Nordisk shares plunge 22% after CagriSema obesity drug trial results
December 20, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Pharmaceuticals
From
CNBC.com News
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
December 18, 2024
Tags
Merck & Co Inc
AstraZeneca PLC
Pfizer Inc
From
CNBC.com News
Europe's economy faces a bumpy ride in 2025. Here are 5 things to watch
December 18, 2024
Tags
Sage Group PLC
Markets
Stock markets
From
CNBC.com News
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
December 17, 2024
Tags
Healthy Returns
Novo Nordisk A/S
Biotech and Pharmaceuticals
From
CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
December 11, 2024
Tags
LILLY DRN
Health & Science
Social issues
From
CNBC.com News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
December 11, 2024
Tags
Biotechnology
Business
Health & Science
From
CNBC.com News
The weight-loss drug boom has become one of the internet's biggest scams
December 08, 2024
Tags
Weight management
Hims & Hers Health Inc
Health care industry
From
CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
December 05, 2024
Tags
Amgen Inc
Social issues
GE HealthCare Technologies Inc
From
CNBC.com News
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
December 05, 2024
Tags
LILLY DRN
US: News
Health & Science
From
CNBC.com News
Hiccups in ETFs tracking MicroStrategy occurring as bull market fuels trading boom in single-stock funds
December 04, 2024
Tags
Markets
Investment strategy
Breaking News: Investing
From
CNBC.com News
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
December 04, 2024
Tags
Biotechnology
Business
Companies
From
CNBC.com News
5 things to know before the stock market opens Tuesday
November 26, 2024
Tags
5 Things to Know
Amgen Inc
Politics
From
CNBC.com News
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
November 26, 2024
Tags
Business News
Breaking News: Business
Pharmaceuticals
From
CNBC.com News
Amgen stock falls as analysts mull over weight loss drug’s bone density data
November 12, 2024
Tags
Amgen Inc
Companies
Health care industry
From
CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
November 08, 2024
Tags
Healthy Returns
Health care industry
AstraZeneca PLC
From
CNBC.com News
Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
October 31, 2024
Tags
Science
Social issues
Health & Science
From
CNBC.com News
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
October 30, 2024
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Pharmaceuticals
From
CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
October 24, 2024
Tags
Companies
Weight management
Alzheimer's disease
From
CNBC.com News
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
October 23, 2024
Tickers
HIMS
LLY
NEWS
NVO
Tags
General
semaglutide
Benzinga
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.